Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dendreon
Dendreon
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Cell Therapeutics
Momenta
Onyx
Amag Pharmaceuticals
Biomarin
M&A
Celgene
Seattle Genetics
Galena Biopharma
ImmunoCellular
Amgen
Celldex
Dendreon
GSK
Vical
Oncothyreon
Biogen Idec
Merck KGaA
Bristol-Myers Squibb
Allos
Spectrum Pharmaceuticals
AstraZeneca
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha
Tue, 08/21/12 - 11:32 am
ImmunoCellular Therapeutics
Dendreon
Jazz Pharmaceuticals
Merck
Verastem
Roche
Oncothyreon
Dendreon's Provenge: Early Stage Use
Seeking Alpha
Mon, 08/20/12 - 10:51 am
Provenge
prostate cancer
Dendreon
JNJ
Dendreon Provenge Sales Wobbling
Seeking Alpha
Mon, 08/20/12 - 10:23 am
prostage cancer
Dendreon
Provenge
Six Disruptive Biotech Stocks
Motley Fool
Sat, 08/18/12 - 03:51 pm
Dendreon
Seattle Genetics
Immunogen
Roche
Vertex Pharmaceuticals
Aveo
Ariad Pharmaceuticals
Isis Pharmaceuticals
3 Things to Watch at Dendreon
Motley Fool
Wed, 08/15/12 - 10:14 pm
Dendreon
Time to Buy: Dendreon?
Motley Fool
Sun, 08/12/12 - 10:58 am
Dendreon
Pluristem's Cell Therapy For Bone Marrow A Blockbuster In The Making
Seeking Alpha
Wed, 08/8/12 - 12:04 pm
Pluristem
Amgen
AstraZeneca
Celgene
Dendreon
Eli Lilly
Medivation
Merck
Onyx
Pfizer
bone marrow disorder
Dendreon Approaching End Of Road, While Other Immunotherapies Thrive
Seeking Alpha
Wed, 08/1/12 - 11:08 am
Dendreon
Galena Biopharma
Can Dendreon Be Saved?
Motley Fool
Wed, 08/1/12 - 07:52 am
Dendreon
Investors Doubt Dendreon’s Restructuring Plans as Provenge Sales Fall
Barron's
Tue, 07/31/12 - 12:20 pm
Dendreon
Provenge
earnings
investors
restructuring
Dendreon Misses, Announces Restructuring; Trading Halted
Barron's
Tue, 07/31/12 - 11:13 am
Dendreon
earnings
Dendreon Cutting More Than 600 Jobs In Cost-Saving Move
Bloomberg
Tue, 07/31/12 - 11:07 am
Dendreon
layoffs
restructuring
Dendreon Earnings Approach
Wall Street Cheat Street
Sun, 07/29/12 - 12:27 pm
Dendreon
earnings
ImmunoCellular Therapeutics Will Benefit As FDA Speeds Up Approval Process
Seeking Alpha
Thu, 07/19/12 - 07:47 am
ImmunoCellular Therapeutics
drug approvals
FDA
Celldex
Dendreon
Jazz Pharmaceuticals
Questcor
Sunesis
Threshold Pharmaceuticals
Spectrum Pharmaceuticals
2 Pharma Companies Investors Should Avoid At Current Levels
Seeking Alpha
Sun, 07/15/12 - 11:39 am
Ampio Pharmaceuticals
Dendreon
Dendreon, Prostate Drug Maker, Sued Over 2011 Stock Drop
Bloomberg
Mon, 07/9/12 - 12:55 pm
Provenge
Dendreon
lawsuits
Dendritic Cell Evolution: Investment Potential
Seeking Alpha
Thu, 07/5/12 - 01:14 pm
Northwest Biotherapeutics
Dendreon
ImmunoCellular
Dendreon shareholders gang up on CEO at annual meeting
Fierce Pharma
Thu, 06/14/12 - 01:18 pm
Dendreon
Pharma CEOs
shareholders
John Johnson
ASCO Data Suggest Dendreon's Provenge Should Go First
Seeking Alpha
Thu, 06/7/12 - 03:29 pm
Provenge
prostate cancer
Dendreon
ASCO
JNJ
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »